Jason Hurt

CEO

Dr. Jason Hurt is a seasoned clinician-scientist and entrepreneur with deep expertise in radiopharmaceutical development, clinical trial strategy, and oncology drug development. In March 2025, he founded Theragnostic Insights, a consulting and strategic advisory firm dedicated to advancing theranostic solutions and radioligand therapies.